{
    "clinical_study": {
        "@rank": "77249", 
        "arm_group": [
            {
                "arm_group_label": "low  body fat percentage", 
                "arm_group_type": "Experimental", 
                "description": "body fat percentage  less than 30%"
            }, 
            {
                "arm_group_label": "heigh body fat percentage", 
                "arm_group_type": "Experimental", 
                "description": "body fat percentage more than 30%"
            }
        ], 
        "brief_summary": {
            "textblock": "The investigators noticed that Body Fat Ratio might have great influence on the efficacy of\n      different lipid soluble anesthetics. The objective of this clinical trial was to compare\n      the effect of  that Body Fat Ratio on the efficacy of different lipid soluble anesthetics."
        }, 
        "brief_title": "Different Lipid Soluble Opioids for Gynecologic Laparoscopic Surgery Postoperative Patient-controlled Analgesia", 
        "completion_date": {
            "#text": "March 2013", 
            "@type": "Actual"
        }, 
        "condition": "Post Operative Pain Management", 
        "condition_browse": {
            "mesh_term": "Pain, Postoperative"
        }, 
        "detailed_description": {
            "textblock": "The objective of this clinical trial was to compare  the effect of  that Body Fat Ratio on\n      the efficacy of different lipid soluble anesthetics."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  American Society of Anesthesiologists grade I-II\n\n          -  adults aged over 20 and below 50 years old,\n\n          -  non-smoker,\n\n          -  with normal hepatic and renal function.\n\n        Exclusion Criteria:\n\n          -  smoker ,\n\n          -  any kind of mental disorder or\n\n          -  history use of analgesics for more than 10 consecutive days,\n\n          -  asthma; and\n\n          -  those with digestion tract disorder who would get nausea or vomiting much more easily\n             than normal people."
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "50 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "180", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "June 14, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01917045", 
            "org_study_id": "LSOPCA-021"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "low  body fat percentage", 
                    "heigh body fat percentage"
                ], 
                "description": "sufentanil 1ug/ml", 
                "intervention_name": "Sufentanil (R30730, brand name Sufenta)", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "low  body fat percentage", 
                    "heigh body fat percentage"
                ], 
                "description": "sufentanil 0.5ug/ml+morphine 0.25mg/ml", 
                "intervention_name": "Sufentanil (R30730, brand name Sufenta) + Morphine", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "low  body fat percentage", 
                    "heigh body fat percentage"
                ], 
                "description": "morphine 0. 5mg/ml", 
                "intervention_name": "Morphine", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Morphine", 
                "Sufentanil", 
                "Analgesics, Opioid"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "sufentanil", 
            "morphine", 
            "postoperative pain control", 
            "body fat percentage", 
            "gynecology laparoscopic surgery", 
            "lipid solubility"
        ], 
        "lastchanged_date": "August 3, 2013", 
        "number_of_arms": "2", 
        "official_title": "Different Lipid Soluble Opioids for Gynecologic Laparoscopic Surgery Postoperative Patient-controlled Analgesia --- a Double Blind Randomized Study", 
        "overall_official": {
            "affiliation": "PKU 1st hospital", 
            "last_name": "zhou yan, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "we evaluate visual analogue pain scores at different time points within 24 hours after surgery", 
            "measure": "visual analogue pain scores", 
            "safety_issue": "No", 
            "time_frame": "24hour"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01917045"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Peking University First Hospital", 
            "investigator_full_name": "ZhouYan", 
            "investigator_title": "M.D", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "we evaluate nausea & vomiting at different time points within 24 hours after surgery. we ask the patient if she feel nausea or/and occured vomit, if so, 1 time will be recorded in the time point for incidence.", 
            "measure": "nausea & vomiting", 
            "safety_issue": "No", 
            "time_frame": "24hour"
        }, 
        "source": "Peking University First Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Peking University First Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}